A recent study in The Foot evaluated the role of minimally invasive orthopedic surgeries (MIOS) for the treatment of diabetic foot disease. Diabetic foot disease is a common diabetes complication. MIOS reduces the length of hospital stay, recovery time, and wound complications. 
The study aimed to determine the effectiveness of MIOS in treating diabetic foot disease.
A number of databases, including Embase, the Cochrane Library, Medline, and Scopus, were searched using particular keywords. Articles were screened for surgical results and demographic information. The analysis comprised 29 studies.
Significant improvements in reduced recurrence rates (0-21%) and ulcer healing times (mean 1.5-3.7 weeks) were shown by distal metatarsal osteotomies, flexor tenotomies, and phalangeal osteotomies. Solid bolt fixation, Taylor Spatial Frame external fixator with percutaneous arthrodesis and metatarsal ray resection, was included in Midfoot MIOS. Promising outcomes with minimal complications were demonstrated by these interventions, specifically in managing Charcot neuroarthropathy. Tibio-talo-calcaneal arthrodesis, a combination of subtalar arthroereisis with Achilles tendon lengthening and vertical contour calcanectomy, was an MIOS technique explored in the hindfoot. Favourable results in lowering post-operative infections (0-3%) and enhancing functional scores (improved American Orthopaedic Foot & Ankle Society scores of 44.8) were shown. Improved plantar forefoot ulcers healing (30 to 57.5 days) in lower leg MIOS, including percutaneous Achilles tendon lengthening and lower recurrence rates (0-38%), were also observed.